An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some experts said the demand for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
Based on TikTok, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.
Digital Trading Activities
Research also discovered communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.
Product Information and Pricing
Within these groups, posts show dark colored parcels with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to potentially significant medical dangers”.
